UPDATE: Needham & Company Downgrades Zynerba Pharmaceuticals (ZYNE) to Hold
Tweet Send to a Friend
(Updated - July 1, 2020 7:22 AM EDT)
(updating comment)Needham & Company analyst Serge Belanger downgraded Zynerba Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updating comment)Needham & Company analyst Serge Belanger downgraded Zynerba Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
